KIT expression in normal and neoplastic renal tissues: Immunohistochemical and molecular genetic analysis

Pathology International

Volumn 55, Issue 8, 2005, Pages 479-483

  Kato, Noriko ^a   Honma, Keiichi ^c   Hojo, Hiroshi ^d   Sasou, Shun Ichi ^b   Matsuzaki, Osamu ^e   Motoyama, Teiichi ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b Yamagata Prefectural Central Hospital   (Japan)

^c Niigata Cancer Center   (Japan)

^d FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^e KIMITSU CHUO HOSPITAL   (Japan)

Author keywords

Angiomyolipoma; Congenital mesoblastic nephroma; Kidney; KIT; Mutations; Platelet derived growth factor receptor

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; STEM CELL FACTOR;

ANGIOMYOLIPOMA; ARTICLE; GENE EXPRESSION; GENE MUTATION; HISTOGENESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; MESOBLASTIC NEPHROMA; MOLECULAR GENETICS; ONCOCYTOMA; PAPILLARY CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADENOMA, OXYPHILIC; ANGIOMYOLIPOMA; CARCINOMA, PAPILLARY; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY NEOPLASMS; KIDNEY TUBULES, COLLECTING; NEPHROMA, MESOBLASTIC; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA;

EID: 23244460349     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2005.01856.x     Document Type: Article

References (37)

1. Higgins JPT, Shinghal R, Gill H et al. Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol 2003; 162: 925-32.
2. Yamazaki K, Sakamoto M, Ohta T, Kanai Y, Ohki M, Hirohashi S. Overexpression of KIT in chromophobe renal cell carcinoma. Oncogene 2003; 22: 847-52.
3. Pan CC, Chen PC, Chiang H. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma. Am J Clin Pathol 2004; 121: 878-83.
4. Miliaras D, Karasawidou F, Papanikolaou A, Sioutopoulou D. KIT expression in fetal, normal adult, and neoplastic renal tissues. J Clin Pathol 2004; 57: 463-6.
5. Petit A, Castillo M, Santos M, Mellado B, Alcover JB, Mallofre C. KIT expression in chromophobe renal cell carcinoma: comparative immunohistochemical analysis of KIT expression in different renal cell neoplasms. Am J Surg Pathol 2004; 28: 676-8.
6. Arber DA, Tamayo R, Weiss LM. Paraffin section detection of the c-kit gene product (CD117) in human tissue: value in the diagnosis of mast cell disorders. Hum Pathol 1998; 29: 498-504.
7. Mirttinen M, Lasota J. Gastrointestinal stromal tumors: definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001; 438: 1-12.
8. Tsuura Y, Hiraki H, Watanabe K et al. Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/dysgerminoma in human: immunohistochemical study of formalin-fixed, paraffin-embedded tissues. Virchows Arch 1994; 424: 135-41.
9. Montone KT, van Belle P, Elenitsas R, Elder DE. Protooncogene c-kit expression in malignant melanoma: protein loss with tumor progression. Mod Pathol 1997; 10: 939-44.
10. Murphy WM, Grignon DJ, Perlman EJ. Tumors of the Kidney, Bladder, and Related Urinary Structures. Atlas of Tumor Pathology, 3rd Series, Fascicle 11. Washington, DC: Armed Forces Institute of Pathology, 1994.
11. Eble JN. Angiomyolipoma of kidney. Semin Diagn Pathol 1998; 15: 21-40.
12. Bolande RP, Brough AJ, Izant RJ. Congenital mesoblastic nephroma of infancy. Pediatrics 1967; 40: 272-8.
13. Makhlouf HR, Remotti HE, Ishak KG. Expression of KIT (CD117) in angiomyolipoma. Am J Surg Pathol 2002; 26: 493-7.
14. Lin ZH, Han EM, Lee ES et al. A distinct expression pattern and point mutation of c-kit in papillary renal cell carcinomas. Mod Pathol 2004; 17: 611-16.
15. Heldin CH. Dimerization of cell surface receptors in signal transduction. Cell 1995; 80: 213-23.
16. Goelz SE, Hamilton SR, Vogelstein B. Purification of DNA from formaldehyde-fixed and paraffin-embedded human tissue. Biochem Biophys Res Commun 1985; 130: 118-26.
17. Barnard M, Lajoie G. Angiomyolipoma: immunohistochemical and ultrastructural study of 14 cases. Ultrastruct Pathol 2001; 25: 21-9.
18. Fetsch PA, Fetsch JF, Marincola FM et al. Comparison of melanoma antigen recognized by T cells (MART-1) to HMB-45: additional evidence to support a common lineage for angiomyolipoma, lymphangiomatosis, and clear cell sugar tumor. Mod Pathol 1998; 11: 699-703.
19. Jungbluth AA, Iversen K, Coplan K et al. Expression of melanocyte-associated markers gp-100 and Melan-A/MART-1 in angiomyolipomas: an immunohistochemical and rt-PCR analysis. Virchows Arch 1999; 434: 429-35.
20. Jungbluth AA, King R, Fisher DE et al. Immunohistochemical and reverse transcription-polymerase chain reaction expression analysis of tyrosinase and microphthalmia-associated transcription factor in anigiomyolipomas. Appl Immunohistochem Mol Morphol 2001; 9: 29-34.
21. Barisella M, Andreola S, Rosai J. CD117 in soft tissue sarcomas. Am J Clin Pathol 2002; 118: 470-71.
22. Cho NH, Shim HS, Choi YD, Kim DS. Estrogen receptor is significantly associated with the epithelioid variants of renal angiomyolipoma. A clinicopathological and immunohistochemical study of 67 cases. Pathol Int 2004; 54: 510-15.
23. Luo R, Gao J, Wehrle-Haller B et al. Molecular identification of distinct neurogenic and melanogenic neural crest sublineages. Development 2003; 130: 321-30.
24. Wehrle-Haller B. The role of kit-ligand in melanocyte development and epidermal homeostasis. Pigment Cell Res 2003; 16: 287-96.
25. Ohashi A, Funasaka Y, Ueda M et al. c-KIT receptor expression in cutaneous malignant melanoma and benign melanotic naevi. Melanoma Res 1996; 6: 25-30.
26. Hornick JL, Fletcher CDM. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol 2002; 117: 188-93.
27. Hirota S, Nishida T, Moriyama Y et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279: 577-80.
28. Hirota S, Nishida T, Isozaki K et al. Gain-of-function mutations at the extracellular domain of KIT in gastrointestinal stromal tumors. J Pathol 2001; 193: 505-10.
29. Heinrich MC, Corless CL, Duensing A et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003; 299: 708-10.
30. Medeiros F, Corless CL, Duensing A et al. KIT-negative gastrointestinal stromal tumors. Proof of concept and therapeutic implications. Am J Surg Pathol 2004; 28: 889-94.
31. Yamamoto H, Oda Y, Kawaguchi K et al. c-kit and PDGFRA mutations in extragastrointestinal stromal tumor (gastrointestinal stromal tumor of the soft tissue). Am J Surg Pathol 2004; 28: 479-88.
32. Huang JS, Huang SS, Kennedy B, Deuel TF. Platelet derived growth factor. Specific to target cells. J Biol Chem 1982; 257: 8130-36.
33. Palman C, Bowen-Pope DF, Brooks JJ. Platelet-derived growth factor receptor (beta-subunit) immunoreactivity in soft tissue tumors. Lab Invest 1992; 66: 108-15.
34. Arbiser JL, Govindarajan B, Bai X et al. A generally applicable method points to a novel role of platelet-derived growth factor receptor-B in tuberous sclerosis. Am J Pathol 2002; 161: 781-6.
35. Heinrich MC, Corless CL, Demetri GD et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 2003; 21: 4342-9.
36. Rubin BP, Chen CJ, Morgan TW et al. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion. Cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol 1998; 153: 1451-8.
37. Knezevich SR, Garnet MJ, Pysher TJ et al. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res 1998; 58: 5046-8.